marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2023
added 10-19-2024
RedHill Biopharma Ltd. Financial Statements 2011-2024 | RDHL
Annual Financial Statements RedHill Biopharma Ltd.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
- | - | 1.2 B | 310 M | 1.8 B | 1.28 B | 908 M | 1.24 B | 1.1 B | 130 M | 78.7 M | 57.9 M | - |
Shares |
- | - | 465 M | 38.4 M | 297 M | 231 M | 177 M | 129 M | 111 M | 8.66 M | 6.24 M | 5.26 M | - |
Historical Prices |
0.43 | 0.92 | 2.58 | 8.08 | 6.07 | 5.55 | 5.14 | 10.5 | 12.9 | 13.3 | 11.8 | - | - |
Net Income |
- | - | -97.7 M | -76.2 M | -42.3 M | -38.8 M | -45.5 M | -29.4 M | -21.1 M | -10.7 M | -10.6 M | -10.3 M | -15.5 M |
Revenue |
6.53 M | 61.8 M | 85.8 M | 64.4 M | 6.29 M | 8.36 M | 4.01 M | 101 K | 3 K | 7.01 M | 12 K | 16 K | 23 K |
Cost of Revenue |
- | - | 49.4 M | 36.9 M | 2.26 M | 2.84 M | 2.13 M | - | - | - | - | - | - |
Gross Profit |
3.07 M | 28.5 M | 36.4 M | 27.5 M | 4.03 M | 5.52 M | 1.88 M | 101 K | 3 K | 5.96 M | 12 K | 16 K | - |
Operating Income |
- | - | -81.1 M | -63.7 M | -43.2 M | -39.3 M | -52 M | -30.5 M | -22 M | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -81.1 M | -63.7 M | -43.2 M | -39.3 M | -52 M | -30.5 M | -22 M | -10.6 M | -10.7 M | -9.02 M | -7.86 M |
Operating Expenses |
- | - | - | 91.2 M | 47.2 M | 44.9 M | 53.9 M | 30.6 M | 22 M | 16.6 M | 10.8 M | 9.06 M | - |
General and Administrative Expenses |
- | - | 32.4 M | 66.6 M | 29.8 M | 20 M | 20 M | 5.4 M | 4.13 M | 4.01 M | 2.68 M | 2.6 M | 2.48 M |
All numbers in USD currency
Quarterly Income Statement RedHill Biopharma Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | - | - | - | - | - | 467 M | - | - | - | 358 M | - | - | - | 284 M | - | - | - | 213 M | - | - | - | 172 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
- | - | - | - | - | - | -29.1 M | - | - | - | -16 M | - | - | - | -10.9 M | - | - | - | -11.1 M | - | - | - | -11 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | 21.5 M | - | - | - | 20.9 M | - | - | - | 1.56 M | - | - | - | 2.35 M | - | - | - | 483 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | 10.6 M | - | - | - | 14.2 M | - | - | - | 425 K | - | - | - | 725 K | - | - | - | 272 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | 10.9 M | - | - | - | 6.71 M | - | - | - | 1.14 M | - | - | - | 1.62 M | - | - | - | 211 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | - | - | - | - | -24.9 M | - | - | - | -12.5 M | - | - | - | -12.4 M | - | - | - | -9.56 M | - | - | - | -13.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | - | - | - | -24.9 M | - | - | - | -12.5 M | - | - | - | -12.4 M | - | - | - | -9.56 M | - | - | - | -13.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
- | - | - | - | - | - | 10.2 M | - | - | - | 6.03 M | - | - | - | 2.4 M | - | - | - | 2.02 M | - | - | - | 1.94 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency